e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Cystic fibrosis: monitoring and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The association between leukocyte telomere length, telomere attrition and disease severity in cystic fibrosis patients
E. Lammertyn (LEUVEN, Belgium)
Source:
International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Session:
Cystic fibrosis: monitoring and biomarkers
Session type:
Oral Presentation
Number:
4402
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Lammertyn (LEUVEN, Belgium). The association between leukocyte telomere length, telomere attrition and disease severity in cystic fibrosis patients. 4402
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Telomere length and genetic variant associations with interstitial lung disease progression and survival
Source: Eur Respir J, 53 (4) 1801641; 10.1183/13993003.01641-2018
Year: 2019
Telomere length in circulating leukocytes is associated with lung function and disease
Source: Eur Respir J 2014; 43: 983-992
Year: 2014
Telomere length in patients with unclassifiable interstitial lung disease: a cohort study
Source: Eur Respir J, 56 (2) 2000268; 10.1183/13993003.00268-2020
Year: 2020
Association between leukocyte telomere length (LTL) and functional decline in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic treatment
Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Year: 2019
Increase in post-transplant survival and quality of life in pulmonary fibrosis with and without telomere dysfunction
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020
Low income and progression free survival in idiopathic pulmonary fibrosis: an association to uncover
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020
Telomerase and telomere length in lung fibrosis: what does it mean?
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016
Telomere (TL) shortening is associated with disease severity in scleroderma (SSC) associated interstitial lung disease (ILD)
Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside
Year: 2012
Association between shorter telomeres’ length and Eotaxin-1 in children with severe asthma, an indicative of accelerated aging.
Source: International Congress 2019 – Cellular metabolism and immune senescence in lung pathology
Year: 2019
Telomere length in blood leukocytes of patients with bronchiectasis
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2007; 30: Suppl. 51, 373s
Year: 2007
The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis
Source: Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018
Year: 2019
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020
Telomere length, COPD and emphysema as risk factors for lung cancer
Source: Eur Respir J 2017; 49(1): 1601521; DOI: 10.1183/13993003.01521-2016
Year: 2017
Post-transplant morbidity and mortality in patients with pulmonary fibrosis and telomeric shortening
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
Peripheral blood leukocyte telomere length is associated with survival of sepsis patients
Source: Eur Respir J, 55 (1) 1901044; 10.1183/13993003.01044-2019
Year: 2020
Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters
Source: Eur Respir J 2004; 24: Suppl. 48, 667s
Year: 2004
Telomere length in circulating leukocytes is associated with lung function and disease
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Longitudinal serological assessment of neutrophil activity is related to disease progression in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept